| Product Code: ETC9208293 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Enteric Disease Testing-Treatment Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Enteric Disease Testing-Treatment Market - Industry Life Cycle |
3.4 Serbia Enteric Disease Testing-Treatment Market - Porter's Five Forces |
3.5 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Therapeutics, 2021 & 2031F |
3.7 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume Share, By Testing Technology, 2021 & 2031F |
3.8 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume Share, By End users, 2021 & 2031F |
4 Serbia Enteric Disease Testing-Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of early detection and treatment of enteric diseases |
4.2.2 Growing investments in healthcare infrastructure and facilities in Serbia |
4.2.3 Rising prevalence of enteric diseases in Serbia due to various factors such as poor sanitation and contaminated water sources |
4.3 Market Restraints |
4.3.1 Limited access to advanced testing and treatment facilities in certain regions of Serbia |
4.3.2 Lack of skilled healthcare professionals specializing in enteric disease testing and treatment |
4.3.3 Economic constraints leading to affordability issues for some patients seeking testing and treatment services |
5 Serbia Enteric Disease Testing-Treatment Market Trends |
6 Serbia Enteric Disease Testing-Treatment Market, By Types |
6.1 Serbia Enteric Disease Testing-Treatment Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Bacterial Enteric Diseases, 2021- 2031F |
6.1.4 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Viral Enteric Diseases, 2021- 2031F |
6.1.5 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Parasitic Enteric Diseases, 2021- 2031F |
6.2 Serbia Enteric Disease Testing-Treatment Market, By Therapeutics |
6.2.1 Overview and Analysis |
6.2.2 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Campylobacter, 2021- 2031F |
6.2.3 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Cryptosporidium, 2021- 2031F |
6.2.4 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By E-Coli, 2021- 2031F |
6.2.5 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Enteroviruses, 2021- 2031F |
6.2.6 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By RhinoViruses, 2021- 2031F |
6.2.7 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By RotaVirus, 2021- 2031F |
6.2.8 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Shigellosis, 2021- 2031F |
6.2.9 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Shigellosis, 2021- 2031F |
6.3 Serbia Enteric Disease Testing-Treatment Market, By Testing Technology |
6.3.1 Overview and Analysis |
6.3.2 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Molecular Diagnostics, 2021- 2031F |
6.3.3 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Monoclonal Antibodies, 2021- 2031F |
6.3.4 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Immunoassays, 2021- 2031F |
6.3.5 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Differential Light Scanning, 2021- 2031F |
6.3.6 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Information Technology, 2021- 2031F |
6.3.7 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By AI, 2021- 2031F |
6.3.8 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.9 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Flow Cytometry, 2021- 2031F |
6.3.10 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Serbia Enteric Disease Testing-Treatment Market, By End users |
6.4.1 Overview and Analysis |
6.4.2 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.4.4 Serbia Enteric Disease Testing-Treatment Market Revenues & Volume, By Physician Offices, 2021- 2031F |
7 Serbia Enteric Disease Testing-Treatment Market Import-Export Trade Statistics |
7.1 Serbia Enteric Disease Testing-Treatment Market Export to Major Countries |
7.2 Serbia Enteric Disease Testing-Treatment Market Imports from Major Countries |
8 Serbia Enteric Disease Testing-Treatment Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare facilities offering enteric disease testing and treatment services |
8.2 Average waiting time for patients to receive enteric disease test results |
8.3 Percentage of the population in Serbia covered by health insurance plans that include enteric disease testing and treatment services |
9 Serbia Enteric Disease Testing-Treatment Market - Opportunity Assessment |
9.1 Serbia Enteric Disease Testing-Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 Serbia Enteric Disease Testing-Treatment Market Opportunity Assessment, By Therapeutics, 2021 & 2031F |
9.3 Serbia Enteric Disease Testing-Treatment Market Opportunity Assessment, By Testing Technology, 2021 & 2031F |
9.4 Serbia Enteric Disease Testing-Treatment Market Opportunity Assessment, By End users, 2021 & 2031F |
10 Serbia Enteric Disease Testing-Treatment Market - Competitive Landscape |
10.1 Serbia Enteric Disease Testing-Treatment Market Revenue Share, By Companies, 2024 |
10.2 Serbia Enteric Disease Testing-Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here